Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Product revenue $ 167 $ 264
Costs of revenue 133 212
Gross profit 34 52
Operating expenses:        
Research and development 836 956 1,554 1,833
General and administrative 615 935 1,586 2,242
Sales and marketing 105 11 164 58
Total operating expenses 1,556 1,902 3,304 4,133
Loss from operations (1,522) (1,902) (3,252) (4,133)
Other income (expenses):        
Interest expense (2) (809) (2) (1,284)
Interest income 115 237
Change in fair value of derivative liabilities 631 1,209 610 2,020
Loss on extinguishment of debt (340)
Offering costs (682) (682)
Loss on extinguishment of derivative liabilities (1,252)
Other income, net 48 3 48 5
Total other income (expense), net 792 (279) 893 (1,533)
Net loss from continuing operations before income taxes (730) (2,181) (2,359) (5,666)
Provision for income taxes
Loss from continuing operations (730) (2,181) (2,359) (5,666)
Loss from discontinued operations (131) (44)
Net loss (730) (2,312) (2,359) (5,710)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock (2,358) (7,334) (2,358) (7,334)
Net loss attributable to common stockholders $ (3,088) $ (9,646) $ (4,717) $ (13,044)
Net loss per share - basic and diluted        
Basic - continuing operations $ (0.78) $ (11.19) $ (2.84) $ (36.66)
Basic - discontinued operations (0.67) (0.28)
Basic - deemed dividend and accretion of a discount on conversion of series B preferred stock (2.53) (37.62) (2.84) (47.46)
Basic - attributable to common stockholders (3.31) (49.48) (5.68) (84.40)
Diluted - continuing operations (1.46) (12.06) (3.58) (39.01)
Diluted - discontinued operations (0.42) (0.28)
Diluted - deemed dividend and accretion of a discount on conversion of series B preferred stock (2.53) (23.33) (2.84) (47.46)
Diluted - attributable to common stockholders $ (3.99) $ (35.81) $ (6.42) $ (86.75)
Weighted average common shares outstanding:        
Basic 931,859 194,933 829,724 154,545
Diluted 931,859 314,354 829,724 154,545